Targeted next-generation sequencing demonstrated similar co-mutational patterns to NK AML, including FLT3 mutations, except NPM1 mutations which were not found in iso +6 (0 vs 44.5% in NK AML, P = 0.0013; Fig. 2A). The gene discussed is NPM1; the disease is acute myeloid leukemia.